Interrelationship between procalcitonin and organ failure in sepsis

被引：22

作者：

Anand D. ^{[1
]}

Das S. ^{[1
]}

Ray S. ^{[2
]}

Bhargava S. ^{[1
]}

Srivastava L.M. ^{[1
]}

机构：

[1] Department of Biochemistry, Sir Ganga Ram Hospital

[2] Department of Critical Care Medicine, Sir Ganga Ram Hospital, New Delhi

来源：

Indian Journal of Clinical Biochemistry | 2014年 / 29卷 / 1期

关键词：

Biomarker; Organ dysfunction; Procalcitonin; Prognosis; Sepsis;

D O I：

10.1007/s12291-013-0326-z

中图分类号：

学科分类号：

摘要：

Sepsis suffers from lack of specific clinical symptoms which contribute to one of the major causes of mortality. In the present study, our aim was to evaluate the role of a recent biomarker Procalcitonin (PCT) in predicting organ dysfunction. 71 patients admitted with sepsis were included in the study. PCT levels were measured at 0, 24, 72 h and 7th day and sequential organ failure assessment score (SOFA) scores were calculated. PCT levels significantly decreased (p < 0.001) in 89.3 % of surviving patients, whereas, in 60 % non surviving patients the PCT level increased significantly (p < 0.001). A significant positive correlation between PCT and SOFA score was observed in survivors at each hour. These observations indicate that PCT concentration is significantly associated with severity of multi organ dysfunction and also helps in determining the prognosis of septic patients. © 2013 Association of Clinical Biochemists of India.

引用

页码：93 / 96

页数：3

共 17 条

[1] Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J., Bohuon C., High serum procalcitonin concentrations in patients with sepsis and infection, Lancet, 341, pp. 515-518, (1993)
[2] Brunkhorst F.M., Wegscheider K., Forycki Z.F., Brunkhorst R., Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock, Intensive Care Med, 26, SUPPL. 2, (2000)
[3] Becker K.L., Snider R., Nylen E.S., Procalcitonin assay in systemic inflammation, infection and sepsis: Clinical utility and limitations, Crit Care Med, 36, 3, pp. 941-952, (2008)
[4] Dandona P., Nix D., Wilson M.F., Aljada A., Love J., Assicot M., Et al., Procalcitonin increase after endotoxin injection in normal subjects, J Clin Endocrinol Metab, 79, pp. 1605-1608, (1994)
[5] Oberhoffer M., Stonans I., Russwurm S., Stonane E., Vogelsang H., Junker U., Et al., Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro, J Lab Clin Med, 134, pp. 49-55, (1999)
[6] Muller B., White J.C., Nylen E.S., Snider R.H., Becker K.L., Habener J.F., Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis, J Clin Endocrinol Metab, 86, pp. 396-404, (2001)
[7] Reinhart K., Meisner M., Biomarkers in the critically ill patient: Procalcitonin, Crit Care Clin, 27, pp. 253-263, (2011)
[8] Luzzani A., Polati E., Dorizzi R., Rungatscher A., Pavan R., Merlini A., Comparison of procalcitonin and C reactive protein as markers of sepsis, Crit Care Med, 1, pp. 1737-1741, (2003)
[9] Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Et al., American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis, Crit Care Med., 20, pp. 864-874, (1992)
[10] Vincent J.L., De Mendonca A., Cantraine F., Moreno R., Takala J., Suter P.M., Et al., Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter prospective study. Working group on "sepsis related problems" of the European society of Intensive Care Medicine, Crit Care Med, 26, pp. 1793-1800, (1998)

← 1 2 →